Form 4: Cardinal Health Director Granted 1,067 Restricted Share Units

Cardinal Health Inc. Director Christine Mundkur was granted 1,067 restricted share units, vesting in November 2026.

Summary

• Christine Mundkur, a Director at Cardinal Health Inc. (CAH), was granted 1,067 common shares in the form of restricted share units.
• The transaction date for this grant was November 5, 2025.
• These restricted share units will vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders occurs before that date.
• Following this transaction, Christine Mundkur beneficially owns 7,536 common shares.
• The grant price for these restricted share units was $0.

Sentiment

Score: 7

Explanation: The filing reports a routine equity grant to a director, which is generally a positive sign of aligning interests, but does not contain significant new operational or financial news to warrant a higher score. It's a standard governance update.

Positives

• The grant of restricted share units to a director aligns interests with shareholders.
• The director's beneficial ownership increased to 7,536 shares, indicating a continued stake in the company.

Risks

• The value of the restricted share units is tied to the future performance of Cardinal Health Inc.'s common shares, meaning the actual value realized upon vesting could be lower than the current market price if the stock declines.

Future Outlook

The vesting of the restricted share units is tied to a future date (November 5, 2026) or the 2026 Annual Meeting of Shareholders, indicating a future alignment of the director's interests with long-term company performance.

Industry Context

This is a standard equity compensation practice for directors in publicly traded companies, aiming to align their interests with long-term shareholder value. It does not provide specific insights into broader industry trends or competitors beyond standard governance practices.

Comparison to Industry Standards

• Granting restricted share units (RSUs) as part of director compensation is a common practice across various industries, including healthcare distribution and services, aligning director incentives with long-term company performance.
• Companies like McKesson Corporation (MCK) and AmerisourceBergen Corporation (ABC), direct competitors of Cardinal Health, also utilize equity-based compensation for their non-employee directors to foster long-term commitment and ownership.
• The $0 transaction price for RSUs is standard, as these are grants rather than purchases, with the value realized upon vesting based on the stock's market price at that time.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of equity compensation to a director aligns their interests with long-term shareholder value, potentially encouraging decisions that benefit the stock price.

Next Steps

• The restricted share units are scheduled to vest on November 5, 2026, or the date of the 2026 Annual Meeting of Shareholders if earlier.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to a director, which is a standard compensation practice aimed at aligning management and director interests with shareholders. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, an investor would likely maintain their current position based solely on this filing.

Keywords

Cardinal Health, CAH, Christine Mundkur, Restricted Share Units, RSU, Director Compensation, Insider Ownership, SEC Form 4, Equity Grant